Organ Tumor Chip Market, Global Outlook and Forecast 2023-2028

Report ID: 1423750 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story

Tumor-on-a-chip can be used to simulate tumor growth and expansion, angiogenesis, and progression from early to advanced lesions involving epithelial–mesenchymal transition (EMT), tumor cell invasion and metastasis.
This report contains market size and forecasts of Organ Tumor Chip in global, including the following market information:
Global Organ Tumor Chip Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Organ Tumor Chip Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Organ Tumor Chip companies in 2021 (%)
The global Organ Tumor Chip market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lung Tumor-on-a-chip Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Organ Tumor Chip include Axosim Technologies, Beonchip, BioIVT, Emulate, InSphero AG, Mimetas, Nortis and Organovo Holdings, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Organ Tumor Chip manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organ Tumor Chip Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ Tumor Chip Market Segment Percentages, by Type, 2021 (%)
Lung Tumor-on-a-chip
Bone Marrow Tumor-on-a-chip
Brain Tumor-on-a-chip
Breast Tumor-on-a-chip
Urinary System Tumor-on-a-chip
Intestine Tumor-on-a-chip
Liver Tumor-on-a-chip
Global Organ Tumor Chip Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ Tumor Chip Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratory
Global Organ Tumor Chip Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Organ Tumor Chip Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ Tumor Chip revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Organ Tumor Chip revenues share in global market, 2021 (%)
Key companies Organ Tumor Chip sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Organ Tumor Chip sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Axosim Technologies
Beonchip
BioIVT
Emulate
InSphero AG
Mimetas
Nortis
Organovo Holdings

Frequently Asked Questions
Organ Tumor Chip Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Organ Tumor Chip Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Organ Tumor Chip Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports